首页> 外文OA文献 >Discontinuation of biosimilar infliximab in Japanese patients with rheumatoid arthritis achieving sustained clinical remission or low disease activity during the IFX-SIRIUS STUDY I (the IFX-SIRIUS STUDY II)

【2h】

Discontinuation of biosimilar infliximab in Japanese patients with rheumatoid arthritis achieving sustained clinical remission or low disease activity during the IFX-SIRIUS STUDY I (the IFX-SIRIUS STUDY II)

机译：日本类风湿性关节炎患者中的生物仿制生物蛋白infliximab在IFX-SIRIUS研究中实现持续的临床缓解或低疾病活动I（IFX-SIRIUS研究II）

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Toshimasa Shimizu; Shin-Ya Kawashiri; Shuntaro Sato; Shimpei Morimoto; Shuri Minoda; Yurika Kawazoe; Shohei Kuroda; Shigeki Tashiro; Remi Sumiyoshi; Naoki Hosogaya; Hiroshi Yamamoto; Atsushi Kawakami;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Remission induction by Raising the dose of Remicade in RA (RRRR) study: Rationale and study protocol for a randomized controlled trial comparing for sustained clinical remission after discontinuation of infliximab in patients with rheumatoid arthritis [J] . Koji Oba, Nao Horie, Norihiro Sato, Contemporary Clinical Trials Communications . 2017,第1期

机译：通过增加RA中的Remicade剂量来诱导缓解（RRRR）：风湿性关节炎患者中英夫利昔单抗停药后的持续临床缓解比较的随机对照试验的原理和研究方案
2. Discontinuation of infliximab after attaining low disease activity in patients with rheumatoid arthritis: RRR (remission induction by Remicade in RA) study. [J] . Tanaka Y, Takeuchi T, Mimori T, Annals of the Rheumatic Diseases: A Journal of Clinical Rheumatology and Connective Tissue Research . 2010,第7期

机译：类风湿关节炎患者达到较低疾病活动后停用英夫利昔单抗：RRR（RA中Remicade诱导缓解）研究。
3. The efficacy, safety and cost-effectiveness of hydroxychloroquine, sulfasalazine, methotrexate triple therapy in preventing relapse among patients with rheumatoid arthritis achieving clinical remission or low disease activity: the study protocol of a randomized controlled clinical Trial (ESCoRT study) [J] . Juan Zhao, Wei Zhou, Yangfeng Wu, BMC Medical Informatics and Decision Making . 2021,第1期

机译：羟基氯喹，磺基甲嘧啶，甲氨蝶呤三重治疗预防风湿性关节炎患者中复发性的疗效，安全性和成本效果，实现临床缓解或低疾病活动：随机对照临床试验的研究方案（护送研究）
4. Early disease control by low-dose prednisone comedication may affect the quality of remission In patients with early rheumatoid arthritis [C] . Monica Todoerti, Carlo Alberto Scire, Nicola Boffini, International Conference on the Neuroendocrine Immune Basis of the Rheumatic Diseases . 2010

机译：低剂量泼尼松的早期疾病控制可能会影响早期类风湿性关节炎患者的缓解质量
5. Clinical studies of immunomodulatory activities of Yunzhi -Danshen in breast cancer and nasopharyngeal carcinoma patients, and Lingzhi-San Miao San in rheumatoid arthritis patients. [D] . Bao, Yixi. 2005

机译：云芝丹参对乳腺癌和鼻咽癌患者及类风湿关节炎灵芝三妙散的免疫调节活性的临床研究。
6. Remission induction by Raising the dose of Remicade in RA (RRRR) study: Rationale and study protocol for a randomized controlled trial comparing for sustained clinical remission after discontinuation of infliximab in patients with rheumatoid arthritis [O] . Koji Oba, Nao Horie, Norihiro Sato, 2017

机译：通过增加RA中的Remicade剂量来诱导缓解（RRRR）：风湿性关节炎患者中英夫利昔单抗停药后持续临床缓解比较的随机对照试验的理论和研究方案
7. Remission induction by Raising the dose of Remicade in RA (RRRR) study: Rationale and study protocol for a randomized controlled trial comparing for sustained clinical remission after discontinuation of infliximab in patients with rheumatoid arthritis [O] . Koji Oba, Nao Horie, Norihiro Sato, 2017

机译：通过提高Ra中Remicade剂量诱导缓解（RRRR）研究：一项随机对照试验的基本原理和研究方案，比较类风湿性关节炎患者停用英夫利昔单抗后的持续临床缓解

Discontinuation of biosimilar infliximab in Japanese patients with rheumatoid arthritis achieving sustained clinical remission or low disease activity during the IFX-SIRIUS STUDY I (the IFX-SIRIUS STUDY II)

著录项

相似文献

相关主题

期刊订阅